Underlying mechanisms of nephroprotective effects with SGLT2i in CKD10' education - June 14, 2019 - ERA-EDTA 2019 - Paola Fioretto, MD – Padua, Italy - Online CME
Paola Fioretto discusses possible underlying mechanisms of the nephroprotective effects of SGLT2i, as observed in large clinical trials.
Video navigation menu
- Possible mechanisms responsible for CV and renal protection with SGLT2i 0:46
- Effects of SGLT2i on renal hemodynamics 2:24
- Potential pathways of renal protective effects with SGLT2i 7:53
This lecture by Paola Fioretto was part of a CME-accredited symposium "SGLT2 Inhibition in CKD: Discussing the key questions and evidence" held during ERA EDTA 2019 in Budapest, Hungary.
Paola Fioretto, MD, Associate Professor in Medicine at the University of Padova, Italy
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Boehringer Ingelheim / Lilly
This is available as accredited online CME on coursepath for members. Click the button below to enroll:Enroll